Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
12 Health Care Stocks Moving In Monday's Intraday Session
How Peter Marks' FDA Departure Is Impacting Pharma, Biotech Stocks
Vertex Non-opioid Painkiller Journavx Gets Mixed ICER Review
Gene Therapy-Focused Bluebird Bio Receives Rival Takeover Offer, Stock Jumps
Barclays Maintains Overweight on Bluebird Bio, Lowers Price Target to $8
Bluebird Bio Analyst Ratings